Clinical Trials
11 trialsNCT05643885 2025-10-20
A Study to Compare Health Care Costs Between Apixaban and Low Molecular Weight Heparin in Patients With Venous Thromboembolism and Cancer
Pfizer
Completed
NCT03098589 2025-03-30
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
Celgene
Completed
NCT02921828 2022-07-05
A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg
Celgene
Completed
NCT02552381 2020-01-07
FICT
Diagnostica Stago R&D
Completed
NCT03099031 2019-12-16
PREDICARE
LEO Pharma
Completed
NCT00253669 2018-06-28
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Completed
NCT01132833 2016-08-22
Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving Chemotherapy
UNC Lineberger Comprehensive Cancer Center
Completed
NCT00676065 2014-11-19
Long-term Active Surveillance Study for Oral Contraceptives (LASS)
Center for Epidemiology and Health Research, Germany
Completed
NCT00433602 2013-06-12
Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Completed
NCT00004875 2011-02-21
Heparin or Enoxaparin in Patients With Cancer
Northwestern University
Completed
NCT00096590 2009-05-12
Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery
National Cancer Institute (NCI)
Completed